MML Investors Services’s Invesco Pharmaceuticals ETF PJP Stock Holding History
Bought
Maintained
Sold
Other funds holding PJP
PAM
JGCM
DBIA
MML Investors Services's PJP Position: Q2 2026 in Review
MML Investors Services increased its Invesco Pharmaceuticals ETF (PJP) stake by 42% in Q2 2026, buying an estimated $1.25M and bringing the position to 39,043 shares worth $4.62M. The position accounts for 0.01% of the portfolio, ranked #1036.
MML Investors Services first reported a position in PJP in Q3 2018 and has held it in 13 quarters since. 117 funds tracked by Wall St. Rank hold PJP as of Q2 2026.
- MML Investors Services held 39,043 shares of Invesco Pharmaceuticals ETF worth $4.62M as of Q2 2026.
- MML Investors Services bought 11,509 Invesco Pharmaceuticals ETF shares in Q2 2026, an estimated $1.25M.
- Invesco Pharmaceuticals ETF made up 0.01% of MML Investors Services's portfolio in Q2 2026, its #1036 holding.
- MML Investors Services first reported a position in Invesco Pharmaceuticals ETF in Q3 2018 and has held it in 13 quarters since.
- 117 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q2 2026.
Based on MML Investors Services's 13F filing for Q2 2026, filed 7 Aug 2026.